45 related articles for article (PubMed ID: 8777418)
1. [Comparison of the efficiency of surgical excision methods for detecting extraprostatic extension and positive resection margin in prostate cancer].
Novikov FV; Tesljuk OS; Efremov GD
Arkh Patol; 2023; 85(5):48-51. PubMed ID: 37814850
[TBL] [Abstract][Full Text] [Related]
2. Distribution of prostatic markers in glands of the female urethra and anterior vaginal wall-a rapid autopsy study.
Haller B; Takano EA; Brock J; Fox SB; Woodford N; Devereux L; O'Connell HE
J Sex Med; 2024 May; ():. PubMed ID: 38808370
[TBL] [Abstract][Full Text] [Related]
3. Prostate MRI for Improving Personalized Risk Prediction of Incontinence and Surgical Planning: The Role of Membranous Urethral Length Measurements and the Use of 3D Models.
Boellaard TN; Hagens MJ; Veerman H; Yakar D; Mertens LS; Heijmink SWTPJ; van der Poel HG; van Leeuwen PJ; Schoots IG; van Dijk-de Haan MC
Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983985
[TBL] [Abstract][Full Text] [Related]
4. Ultrasensitive prostate specific antigen after prostatectomy reliably identifies patients requiring postoperative radiotherapy.
Kang JJ; Reiter RE; Steinberg ML; King CR
J Urol; 2015 May; 193(5):1532-8. PubMed ID: 25463990
[TBL] [Abstract][Full Text] [Related]
5. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of benign glands at surgical margins in robotic radical prostatectomy specimens.
Kohl SK; Balaji KC; Smith LM; Wilson NP; Johansson SL; Sterrett SP; Abrahams NA
Urology; 2007 Jun; 69(6):1112-6. PubMed ID: 17572197
[TBL] [Abstract][Full Text] [Related]
7. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
Blute ML; Bostwick DG; Bergstralh EJ; Slezak JM; Martin SK; Amling CL; Zincke H
Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
[TBL] [Abstract][Full Text] [Related]
9. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
10. [Peroperative biopsy of the sub-apical urethra during prostatectomy for cancer].
Ponthieu A; Delgrande J; Ivaldi A
Prog Urol; 1996 Apr; 6(2):250-5; discussion 255-6. PubMed ID: 8777418
[TBL] [Abstract][Full Text] [Related]
11. Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer.
Wieder JA; Soloway MS
J Urol; 1998 Aug; 160(2):299-315. PubMed ID: 9679867
[TBL] [Abstract][Full Text] [Related]
12. Avoidance and management of positive surgical margins before, during and after radical prostatectomy.
Bott SR; Kirby RS
Prostate Cancer Prostatic Dis; 2002; 5(4):252-63. PubMed ID: 12627209
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
